UroGen Pharma Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 11/14/2024 | 3.79 M | $48.10 M | 6.47% | 8.79% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 3.74 M | $47.44 M | 13.20% | 8.67% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 2.50 M | $31.72 M | 100.00% | 5.80% |
| MENORA MIVTACHIM HOLDINGS LTD. | 11/14/2024 | 2.30 M | $29.25 M | 0.00% | 5.34% |
| MORGAN STANLEY | 11/14/2024 | 2.18 M | $27.70 M | 18.64% | 5.06% |
| COWEN AND COMPANY, LLC | 11/12/2024 | 1.80 M | $22.82 M | -14.43% | 4.17% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2024 | 1.55 M | $19.69 M | -6.06% | 3.60% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 1.51 M | $19.13 M | -38.49% | 3.50% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.50 M | $19.04 M | 29.14% | 3.48% |
| JEFFERIES FINANCIAL GROUP INC. | 11/14/2024 | 965,000 | $12.26 M | 0.00% | 2.24% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 901,129 | $11.44 M | -18.23% | 2.09% |
| STATE STREET CORP | 11/14/2024 | 769,583 | $9.77 M | 5.90% | 1.79% |
| GREAT POINT PARTNERS LLC | 11/13/2024 | 758,786 | $9.64 B | -73.89% | 1.76% |
| MIGDAL INSURANCE & FINANCIAL HOLDINGS LTD. | 11/04/2024 | 686,472 | $8.72 M | 0.00% | 1.59% |
| WILDCAT CAPITAL MANAGEMENT, LLC | 11/08/2024 | 495,606 | $6.29 B | 0.00% | 1.15% |
| HAREL INSURANCE INVESTMENTS & FINANCIAL SERVICES LTD. | 10/15/2024 | 463,267 | $5.88 M | -0.06% | 1.07% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 458,915 | $5.83 M | -2.15% | 1.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 455,637 | $5.79 M | 8.13% | 1.06% |
| OPALEYE MANAGEMENT INC. | 11/14/2024 | 404,100 | $5.13 M | -1.92% | 0.94% |
| VESTAL POINT CAPITAL, LP | 11/14/2024 | 400,000 | $5.08 M | 100.00% | 0.93% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 347,541 | $4.41 M | 26.62% | 0.81% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 315,957 | $4.01 M | 19.86% | 0.73% |
| WOODLINE PARTNERS LP | 11/14/2024 | 305,642 | $3.88 M | 0.63% | 0.71% |
| VANGUARD GROUP INC | 11/13/2024 | 284,437 | $3.61 M | 26.99% | 0.66% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 11/13/2024 | 280,345 | $3.56 M | 100.00% | 0.65% |
| RICE HALL JAMES & ASSOCIATES, LLC | 10/28/2024 | 271,897 | $3.45 M | 273.55% | 0.63% |
| TREXQUANT INVESTMENT LP | 11/12/2024 | 271,670 | $3.45 M | 236.60% | 0.63% |
| CITADEL ADVISORS LLC | 11/14/2024 | 242,066 | $3.07 M | 225.52% | 0.56% |
| STEMPOINT CAPITAL LP | 11/13/2024 | 241,984 | $3.07 M | 100.00% | 0.56% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 215,739 | $2.74 M | -0.05% | 0.50% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 149,387 | $1.90 M | 60.71% | 0.35% |
| AWM INVESTMENT COMPANY, INC. | 11/14/2024 | 139,886 | $1.78 M | 1,298.86% | 0.32% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 137,300 | $1.74 M | -12.03% | 0.32% |
| EPOCH INVESTMENT PARTNERS, INC. | 11/13/2024 | 136,872 | $1.74 M | 100.00% | 0.32% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 124,300 | $1.58 M | -49.96% | 0.29% |
| ARK INVESTMENT MANAGEMENT LLC | 10/31/2024 | 121,634 | $1.54 M | -19.86% | 0.28% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 117,939 | $1.50 M | 289.37% | 0.27% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 107,645 | $1.37 M | 100.00% | 0.25% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 90,493 | $1.15 M | 9.14% | 0.21% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 87,567 | $1.11 M | -9.37% | 0.20% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 87,034 | $1.11 M | -13.33% | 0.20% |
| DE LISLE PARTNERS LLP | 11/14/2024 | 81,510 | $1.04 M | 0.00% | 0.19% |
| OAK RIDGE INVESTMENTS LLC | 10/28/2024 | 76,799 | $975,347 | -3.92% | 0.18% |
| ANNANDALE CAPITAL, LLC | 11/12/2024 | 75,552 | $960,000 | 0.00% | 0.18% |
| WESBANCO BANK INC | 10/11/2024 | 74,400 | $944,880 | 100.00% | 0.17% |
| JPMORGAN CHASE & CO | 11/08/2024 | 68,062 | $864,388 | 263.11% | 0.16% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 66,489 | $844,410 | 0.61% | 0.15% |
| BARCLAYS PLC | 11/19/2024 | 59,778 | $759,000 | 409.27% | 0.14% |
| SWISS NATIONAL BANK | 11/07/2024 | 56,600 | $718,820 | 100.00% | 0.13% |
| JUMP FINANCIAL, LLC | 11/14/2024 | 56,450 | $716,915 | 100.00% | 0.13% |
UroGen Pharma Ltd.institutional Ownership - FAQ's
During the previous two years, 146 institutional investors and hedge funds held shares of UroGen Pharma Ltd.. The most heavily invested institutionals were:
RTW INVESTMENTS, LP: 3.79 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 3.74 M
BlackRock Funding, Inc. /DE: 2.5 M
MENORA MIVTACHIM HOLDINGS LTD.: 2.3 M
MORGAN STANLEY: 2.18 M
COWEN AND COMPANY, LLC: 1.8 M
81.50% of UroGen Pharma Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 39.02 M shares in the last 24 months. This purchase volume represents approximately $422.16 M in transactions.